It was a pleasure to meet Peter Baker, Independent Men’s Health Consultant , at the ECCO 2019 European Cancer Summit in Brussels to discuss the HPV Action UK, the successful campaign to achieve gender neutral HPV vaccination in the UK and progress towards establishing a similar campaign at the European level.
1 Tell us a bit about the work you have been doing in the UK… (0:08)
2. Since its introduction over a decade ago, how much impact has the human papilloma virus (HPV) vaccine had on the incidence of cervical, oral and other cancers worldwide? (1:05)
How would the gender-neutral vaccination against HPV decrease the spread of HPV and consequent cancers? (2:36)
3. What would be the main benefits of a gender neutral vaccination across Europe? (4:25)
4. What are the prospects for a future total eradication of HPV? (4:52)
5. What are the main obstacles to achieving this goal? (5:13)
Peter Baker has no conflicts of interest to declare in relation to this video.
Filmed in partnership with the European CanCer Organisation at the ECCO 2019 European Cancer Summit in Brussels, Belgium.
Share this Video
Related Videos In Policy
Raising awareness around HPV infection, cancer risk and vaccination: PrEvCan | Daniel Kelly
The PrEvCan – Cancer Prevention Across Europe – campaign, initiated by the European Oncology Nursing Society (EONS) and supported by ESMO, aims to reduce the burden of cancer by promoting a different way we can decrease cancer risk each month. This August, the PrEvCan campaign focuses on raising awareness about the connection between human papillomavirus […]
Vivek Subbiah, AACR 2023: The purpose of phase I clinical trials
The purpose of phase I clinical trials are to evaluate the safety, dosage and potential side effects of a new drug or treatment in humans for the first time. In this touchONCOLOGY interview, we speak with Dr Vivek Subbiah (University of Texas, MD Anderson Cancer Centre, Houston, TX, USA) to discuss the purpose and details […]
Vivek Subbiah, AACR 2023: The evolution of phase I clinical trials in the era of precision medicine
Precision medicine aims to tailor medical treatments to individual patients based on their characteristics and genetic makeup. Phase I clinical trials are seeing changes in their objectives and designs in the era of precision medicine. In this touchONCOLOGY interview, we speak with Dr Vivek Subbiah (University of Texas, MD Anderson Cancer Centre, Houston, TX, USA) […]